Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.
about
Recent Advances in Lentiviral Vaccines for HIV-1 InfectionGene therapy on the moveHighly efficient baculovirus-mediated multigene delivery in primary cells.Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cellsAn ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse modelCurrent prospects for RNA interference-based therapiesSpecific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptorsEndothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin ATargeting tumor suppressor networks for cancer therapeutics.Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivoNovel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleasesGene therapy for inherited immunodeficiency.Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.Library screening and receptor-directed targeting of gammaretroviral vectors.DARPins: an efficient targeting domain for lentiviral vectors.Preferential lentiviral targeting of astrocytes in the central nervous system.A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs).CD133-targeted gene transfer into long-term repopulating hematopoietic stem cellsEnvelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.Gene therapy for the nervous system: challenges and new strategies.Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsHolo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.Targeted entry of enveloped viruses: measles and herpes simplex virus I.IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment.Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivoVectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells.The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function.Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancersMethod for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial CellsDynamic lineage analysis of embryonic morphogenesis using transgenic quail and 4D multispectral imaging.Virally mediated gene manipulation in the adult CNS.The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand bindingReceptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv.A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.Improved retroviral episome transfer of transcription factors enables sustained cell fate modification.
P2860
Q26742169-30A0514E-6036-4E90-8213-1033949EDCD1Q27007012-7872C3D7-1D0F-43F1-A17D-AAF6B67851B2Q27317062-6BB44126-EB06-4477-9EBA-F8DBE7F3EEF3Q27318247-06A474F9-42BF-435F-8F7D-0D1DE14C1503Q27697593-E146C38B-F21A-43F7-A17F-C6EE9061EC9AQ28235733-BB36E5BA-F657-4654-ABD8-5BC4F50E1E62Q30583252-5D8C2382-46CA-4D1D-9994-E1F0B64EA8BCQ33569270-4B787198-3661-4E70-9767-CF29AAD4D894Q33657519-BEB6B50D-7153-482B-AC84-E9AF8807CB65Q33945680-ED6CD73A-78E1-49FB-BC44-24759FD329ADQ34200828-F3F0D25A-6289-477B-B4B6-686F07EEC9B5Q34419791-F88C34B7-7941-485D-B29A-47E43F6E58ABQ34447329-4355C543-2427-45A7-B4A2-0804358B2EC6Q34517833-B6994E45-F598-4F1A-B07E-ADCFB776287FQ34757199-6A844510-EA6E-471B-92A5-547237A8BFC4Q35009241-13E53873-7819-47DB-B2B7-690E9D2BC9C0Q35214817-93F6E5E4-4865-4978-9EE7-077A4605CED7Q35238704-15CA3652-9AB0-4F70-9450-E99A54DEABB0Q35285887-0276C809-77FA-4675-B63E-1ABFB1ECC876Q35340196-DFFA33FA-3B81-426C-93CE-70BAC91F3A95Q35666025-60F44266-6A96-4AB2-8EDF-90D5B808002BQ35679568-A9AF0A82-64A9-4C74-8B16-C909FB2C6E04Q35851724-A315924D-D588-434F-84DF-74593CBDFFCFQ35992493-15B4FD33-F722-4970-BC91-CFE39BB4638AQ36047074-7E6A090C-A2F8-438E-A143-8776D9653A39Q36220659-8EAE2989-39F8-410B-9317-5782A7C8E40FQ36298623-6268D021-CB26-4FE7-A971-BECBB7A78760Q36607409-1E7BC955-FB8C-4BCD-976E-3E753A4819B9Q36757162-C4DFFA6F-C43D-4544-800E-FAFB7F66862FQ36827199-DCA766EC-4C8F-4F91-89EF-4B0AA4B2785FQ37358531-C12DB7D6-9A02-4689-A942-86834453B7DEQ37362037-90FED671-CFB6-406A-B71C-FE6E550B112EQ37633922-C57C2482-4D6F-45BD-A14E-3EFA34E0DC92Q37642712-F9CF37AD-D2D8-4B05-88E3-3AF57AFB36B6Q37867601-0608CCEA-4720-4F8F-8D90-C7737FD848E4Q37972291-60BE43D8-13C8-4FA0-84B9-432CBEE871E1Q38323488-9383F614-A010-40BC-AE48-19D265D5486AQ38906090-51CC8716-8A34-4C42-805F-2F847A3FBF6EQ38917869-A6183020-72F4-4B0D-9057-85F7F5F0E99CQ38968105-346428BE-F1CB-4FEB-B373-81A7FAE74E54
P2860
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Specific gene transfer to neur ...... itors with lentiviral vectors.
@en
Specific gene transfer to neur ...... itors with lentiviral vectors.
@nl
type
label
Specific gene transfer to neur ...... itors with lentiviral vectors.
@en
Specific gene transfer to neur ...... itors with lentiviral vectors.
@nl
prefLabel
Specific gene transfer to neur ...... itors with lentiviral vectors.
@en
Specific gene transfer to neur ...... itors with lentiviral vectors.
@nl
P2093
P2860
P356
P1433
P1476
Specific gene transfer to neur ...... itors with lentiviral vectors.
@en
P2093
Antonio Caputi
Brigitte Anliker
Christian J Buchholz
Christine Hohenadl
Helga Petznek
Ian C D Johnston
Irene C Schneider
Julia Brynza
Juraj Hlavaty
Kari Keinänen
P2860
P2888
P304
P356
10.1038/NMETH.1514
P577
2010-10-10T00:00:00Z